These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34948010)

  • 1. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme.
    Kaynar A; Altay O; Li X; Zhang C; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.
    Lan Z; Li X; Zhang X
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System-based approaches as prognostic tools for glioblastoma.
    Salvucci M; Zakaria Z; Carberry S; Tivnan A; Seifert V; Kögel D; Murphy BM; Prehn JHM
    BMC Cancer; 2019 Nov; 19(1):1092. PubMed ID: 31718568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach.
    Kaynar A; Ozcan M; Li X; Turkez H; Zhang C; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal long non-coding RNAs in glioblastoma.
    Fattahi M; Alamdari-Palangi V; Rahimi Jaberi K; Ehtiati S; Ojaghi S; Rahimi-Jaberi A; Samavarchi Tehrani S; Dang P; Movahedpour A; Hossein Khatami S
    Clin Chim Acta; 2024 Jan; 553():117705. PubMed ID: 38086498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the key genes and signaling transduction pathways related to the survival time of glioblastoma multiforme patients by a novel survival analysis model.
    Xia Y; Yang C; Hu N; Yang Z; He X; Li T; Zhang L
    BMC Genomics; 2017 Jan; 18(Suppl 1):950. PubMed ID: 28198665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the personalized driver gene sets maximally contributing to abnormality of transcriptome phenotype in glioblastoma multiforme individuals.
    Xu J; Pang B; Lan Y; Dou R; Wang S; Kang S; Zhang W; Liu Y; Zhang Y; Ping Y
    Mol Oncol; 2023 Nov; 17(11):2472-2490. PubMed ID: 37491836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme.
    You Y; Ru X; Lei W; Li T; Xiao M; Zheng H; Chen Y; Zhang L
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):383. PubMed ID: 32938364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening.
    Fang Y; Li X; Tian R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
    Tomoszková S; Škarda J; Lipina R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
    Gatto L; Franceschi E; Di Nunno V; Tosoni A; Lodi R; Brandes AA
    Oncologist; 2021 Oct; 26(10):865-878. PubMed ID: 34105205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering strategies to mimic the glioblastoma microenvironment.
    Rape A; Ananthanarayanan B; Kumar S
    Adv Drug Deliv Rev; 2014 Dec; 79-80():172-83. PubMed ID: 25174308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Molecular and Clinical Biomarkers of Survival in Glioblastoma Multiforme Patients: A Study Based on The Cancer Genome Atlas Data.
    Esteves L; Caramelo F; Roda D; Carreira IM; Melo JB; Ribeiro IP
    Biomed Res Int; 2024; 2024():5582424. PubMed ID: 38606198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
    Nassani R; Bokhari Y; Alrfaei BM
    PLoS One; 2023; 18(11):e0287448. PubMed ID: 37972206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic Glutamate Receptors Type 3 and 5 Feature the "NeuroTransmitter-type" of Glioblastoma: A Bioinformatic Approach.
    Caridi M; Alborghetti M; Pellicelli V; Orlando R; Pontieri FE; Battaglia G; Arcella A
    Curr Neuropharmacol; 2024; 22(11):1923-1939. PubMed ID: 38509672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics sciences and precision medicine in glioblastoma.
    Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteogenomic and metabolomic characterization of human glioblastoma.
    Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L;
    Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Analysis of Multi-Omics Data Based on Blockwise Sparse Principal Components.
    Park M; Kim D; Moon K; Park T
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.
    Kumari S; Gupta R; Ambasta RK; Kumar P
    Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188913. PubMed ID: 37182666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems Medicine for Precise Targeting of Glioblastoma.
    Zeng J; Zeng XX
    Mol Biotechnol; 2023 Oct; 65(10):1565-1584. PubMed ID: 36859639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.